Innovative Eyewear (LUCY) Cash from Financing Activities (2021 - 2025)
Innovative Eyewear (LUCY) posted Cash from Financing Activities of $336965.0 for Q4 2025, down 42.34% sequentially from $584402.0 in Q3 2025, and up 275.03% YoY from $89851.0 in Q4 2024.
Innovative Eyewear (LUCY) Cash from Financing Activities (2021 - 2025) Analysis & Trends
Innovative Eyewear has reported Cash from Financing Activities for 5 years, with the latest figure at $336965.0 in Q4 2025.
- Quarterly Cash from Financing Activities rose 275.03% year-over-year to $336965.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.0 million (down 40.99% YoY) and the FY2025 annual result came in at $6.7 million, down 34.77% from the prior year.
- Cash from Financing Activities fell to $336965.0 in Q4 2025 per LUCY's latest filing, from $584402.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $6.0 million in Q3 2022 and troughed at -$285137.0 in Q4 2023.
- A 5-year average of $1.6 million and a median of $481528.0 in 2021 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities plunged 145.15% in 2022, then surged 24865.23% in 2024.
- Over 5 years, Cash from Financing Activities stood at $449593.0 in 2021, then slumped by 145.15% to -$203000.0 in 2022, then tumbled by 40.46% to -$285137.0 in 2023, then soared by 131.51% to $89851.0 in 2024, then soared by 275.03% to $336965.0 in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $336965.0, $584402.0, and $89851.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Innovative Eyewear | 4.37 Mn | 1.91 Mn | 242,515.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 336,965.00 |
| Dec 31, 2025 | 336,965.00 |
| Sep 30, 2025 | 584,402.00 |
| Sep 30, 2025 | 584,402.00 |
| Dec 31, 2024 | 89,851.00 |
| Dec 31, 2024 | 89,851.00 |
| Sep 30, 2024 | 5.03 Mn |
| Sep 30, 2024 | 5.03 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Mar 31, 2024 | -75,988.00 |
| Mar 31, 2024 | -75,988.00 |
| Dec 31, 2023 | -285,137.00 |
| Dec 31, 2023 | -285,137.00 |
| Sep 30, 2023 | -20,325.00 |
| Sep 30, 2023 | -20,325.00 |
| Jun 30, 2023 | 5.61 Mn |
| Jun 30, 2023 | 5.61 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.36 Mn |